These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans. Kimmel SE; Christie J; Kealey C; Chen Z; Price M; Thorn CF; Brensinger CM; Newcomb CW; Whitehead AS Pharmacogenomics J; 2008 Feb; 8(1):53-60. PubMed ID: 17325732 [TBL] [Abstract][Full Text] [Related]
7. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients. Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439 [TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical predictors of warfarin dose requirements in African Americans. Cavallari LH; Langaee TY; Momary KM; Shapiro NL; Nutescu EA; Coty WA; Viana MA; Patel SR; Johnson JA Clin Pharmacol Ther; 2010 Apr; 87(4):459-64. PubMed ID: 20072124 [TBL] [Abstract][Full Text] [Related]
9. Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Limdi NA; Arnett DK; Goldstein JA; Beasley TM; McGwin G; Adler BK; Acton RT Pharmacogenomics; 2008 May; 9(5):511-26. PubMed ID: 18466099 [TBL] [Abstract][Full Text] [Related]
10. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846 [TBL] [Abstract][Full Text] [Related]
11. New genetic variant that might improve warfarin dose prediction in African Americans. Schelleman H; Brensinger CM; Chen J; Finkelman BS; Rieder MJ; Kimmel SE Br J Clin Pharmacol; 2010 Sep; 70(3):393-9. PubMed ID: 20716240 [TBL] [Abstract][Full Text] [Related]
12. The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Perera MA; Gamazon E; Cavallari LH; Patel SR; Poindexter S; Kittles RA; Nicolae D; Cox NJ Clin Pharmacol Ther; 2011 Mar; 89(3):408-15. PubMed ID: 21270790 [TBL] [Abstract][Full Text] [Related]
14. Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Ramirez AH; Shi Y; Schildcrout JS; Delaney JT; Xu H; Oetjens MT; Zuvich RL; Basford MA; Bowton E; Jiang M; Speltz P; Zink R; Cowan J; Pulley JM; Ritchie MD; Masys DR; Roden DM; Crawford DC; Denny JC Pharmacogenomics; 2012 Mar; 13(4):407-18. PubMed ID: 22329724 [TBL] [Abstract][Full Text] [Related]
15. A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation. Wei M; Ye F; Xie D; Zhu Y; Zhu J; Tao Y; Yu F Thromb Haemost; 2012 Jun; 107(6):1083-91. PubMed ID: 22534826 [TBL] [Abstract][Full Text] [Related]
16. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797 [TBL] [Abstract][Full Text] [Related]